Malignant glomus tumors (MGTs) are exceptional but pose diagnostic and therapeutic challenges. Wide resection is the recommended treatment method, however, no data are available concerning adjuvant therapies.
Introduction
Glomus tumors (GTs) are rare neoplasms originating from the glomus body. 1 Glomus tumors are classified into common or solid form, glomangioma, and glomangiomyoma according to histological features. 1, 2 Overall, GTs account for about 1.5% of soft tissue tumors, being mostly located in the forearm and the subungual area of the digits, 1, 3, 4 and multiple GTs account for 25% of the cases. 5 The average duration of symptoms is reported to be between 7 and 11 years before diagnosis, and a wide excision is generally required. 1 Despite the fact that GTs are commonly considered benign, malignancy should be considered if they are deep-seated (under muscular fascia), larger than 2 cm, or in the presence of specific histologic features such as nuclear atypia, necrosis, or mitotic activity. 6 Fatal cases with distant metastases are occasionally reported, comprising less than 1% of all glomus tumors. Both malignant glomus tumors and glomus tumors of uncertain malignant potential are rarely diagnosed (2.9% and 3.6%, respectively). 6 At the moment, few data are available for either therapeutic strategies for malignant glomus tumors, or adjuvant therapies.
We present an exceptional case of extradigital deep-seated MGT of the forearm, with an exceptional bone infiltration. Despite being treated with wide resection, the patient had an optimal functional outcome, no functional loss, no motor or sensitive deficits and has returned to his full daily activity.
Case report
A 46-year-old male patient presented to our clinic due to a mass he discovered on the right forearm five years ago, which was kept under control with periodically performed echo sonographies. He did not have any pain-related symptoms. The patient was only able to use his right arm due to a not well-defined cerebral ischemic event he had during his childhood which ended in paralysis of the left upper limb. Images on echography between controls were usually superimposable until a certain growth of that mass was detected. The patient stated that the radiologists described the mass as a benign cyst which had to be followed up once a year. Unfortunately, we neither have written documentation of those years nor the images of the ultrasounds performed. Five months before, the patient was advised by his primary care physician to undergo an MRI of the right forearm for a visible growth of the neoplasm coupled with the onset of an inflammatory pain on the wrist. A large mass (7 Â 1.5 Â 1.2 cm), which showed a hypersignal on T2-weighted images and an intermediate signal on T1-weighted images and full-contrast enhancement was detected. The lobulated mass which infiltrated the ulna was located anteriorly to the tendon of the ulnar carpal extensor and posteriorly to the ulnar carpal flexor. It had a necrotic area near to the distal ulna, infiltrated at a depth of 0.5 cm and with a length of 1.6 cm (Figs. 1e3) . The core specimen biopsy detected a glomangioma with no histological signs of malignancy (Fig. 4) . We performed a wide resection of the neoplasm, including the right distal ulna (the size of the tumor was 6 Â 3 Â 1 cm). Histological analysis of the resected mass confirmed specimen findings as glomangioma and wide margins of resection (Figs. 5e7) We followed up our patient clinically and radiologically at 3-month intervals (Fig. 8) . During the 24th month of the followup, he underwent MRIs of the forearm and radiographs of the chest. Despite the wide resection, the patient had an optimal functional outcome, no functional loss, no motor or sensitive deficits and has returned to his full daily activity. No signs of recurrence or metastases were reported.
Discussion
We reviewed 40 cases of forearm glomangiomas or malignant glomus tumors described in 13 case reports, one case report review and three retrospective single center studies from 1982 to 2016. The mean size of all the tumors we reviewed was 1.37 cm. The biggest forearm glomus neoplasm was 14 cm in length, but had an intravascular growth in the venous system. 7 In one study, an intraosseous growth of a small GT, as in osteoid osteoma, was treated with bone excision, but neither bone erosion nor infiltration was reported. 8 One malignant and one atypical GT reported in two other studies 9,10 were treated with surgical excision without adjuvant therapy. However, little data about the follow-up were available since the follow-ups usually had a short duration or did not even take place (Table 1) . Glomus tumors, as a very rare group of neoplasms pose diagnostic and therapeutic challenges. Extradigital tumors comprise 27% of the GTs, with the forearm being the most common location. The tumors have an average size of 0.66 cm, ranging from 0.1 to 3 cm. 1, 3 On MRI, these neoplasms show an intermediate signal on T1-weighted and a high signal on T2-weighted images with homogeneous contrast enhancement; and larger masses can be lobulated. On echography, glomus tumors present as circumscribed, solid hypoechoic masses that may show small cystic-shaped spaces. Marked blood flow within the masses has been observed on power Doppler and color Doppler ultrasonography. 12, 13 Malignant GTs account for 2.9% of all GTs and little data is available about their treatment and follow-up. Mainly all data about MGTs are included in a small retrospective study or in few case reports. Our case was about a glomus tumor with exceptional characteristics. The mass had unusual dimensions; one of the biggest reported in the literature. This neoplasm showed also bone infiltration in the forearm, which was never reported. Although histological characteristics showed no signs of malignancy on biopsy and surgical specimens, we considered our case as an MGT. As Folpe et al 6 suggested, its big dimensions and deep position were considered as the markers of malignancy. We performed wide resection, prioritizing the survival of the patient rather than achieving a functional outcome, although our patient had neurological disability. We set a radiological and clinical followup each three months for the first two years after surgery since we expected a high risk of recurrence. The criteria to distinguish MGTs derive from a retrospective study of 52 unusual cases, whose conclusions are not supported by strong statistical analysis, and the statistical analysis in estimating the relative risks of malignancy lacked confidence interval and significance due to the small sample size. In such a scenario, the surgeon's experience plays a fundamental role in treatment planning. There is also no significant data about adjuvant treatments. Oncological reference hospitals should share their data and plan for trials to have more information about the diagnosis, classification and treatment of unusual and malignant GTs.
In conclusion, planning therapeutic strategies for this rare case is challenging. The literature usually consists of case reports but very few reviews. Considering the increase in the number of case reports on GTs in recent years, we should find a standardized way to collect all data in the case reports. Having more standardized data should help in planning better therapeutic strategies.
